353 related articles for article (PubMed ID: 35682722)
1. Muscle Wasting in Chronic Kidney Disease: Mechanism and Clinical Implications-A Narrative Review.
Cheng TC; Huang SH; Kao CL; Hsu PC
Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682722
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle wasting in chronic kidney disease: the emerging role of microRNAs.
Robinson KA; Baker LA; Graham-Brown MPM; Watson EL
Nephrol Dial Transplant; 2020 Sep; 35(9):1469-1478. PubMed ID: 31603229
[TBL] [Abstract][Full Text] [Related]
3. Pro-cachectic factors link experimental and human chronic kidney disease to skeletal muscle wasting programs.
Solagna F; Tezze C; Lindenmeyer MT; Lu S; Wu G; Liu S; Zhao Y; Mitchell R; Meyer C; Omairi S; Kilic T; Paolini A; Ritvos O; Pasternack A; Matsakas A; Kylies D; Wiesch JSZ; Turner JE; Wanner N; Nair V; Eichinger F; Menon R; Martin IV; Klinkhammer BM; Hoxha E; Cohen CD; Tharaux PL; Boor P; Ostendorf T; Kretzler M; Sandri M; Kretz O; Puelles VG; Patel K; Huber TB
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 34060483
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of muscle wasting in chronic kidney disease.
Wang XH; Mitch WE
Nat Rev Nephrol; 2014 Sep; 10(9):504-16. PubMed ID: 24981816
[TBL] [Abstract][Full Text] [Related]
5. Suppression of muscle wasting by the plant-derived compound ursolic acid in a model of chronic kidney disease.
Yu R; Chen JA; Xu J; Cao J; Wang Y; Thomas SS; Hu Z
J Cachexia Sarcopenia Muscle; 2017 Apr; 8(2):327-341. PubMed ID: 27897418
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: a new therapeutic frontier for muscle wasting in chronic kidney disease.
Mak RH; Cheung WW
Kidney Int; 2012 Aug; 82(4):373-4. PubMed ID: 22846810
[TBL] [Abstract][Full Text] [Related]
7. Satellite cell dysfunction and impaired IGF-1 signaling cause CKD-induced muscle atrophy.
Zhang L; Wang XH; Wang H; Du J; Mitch WE
J Am Soc Nephrol; 2010 Mar; 21(3):419-27. PubMed ID: 20056750
[TBL] [Abstract][Full Text] [Related]
8. Organ Crosstalk Contributes to Muscle Wasting in Chronic Kidney Disease.
Wang XH; Price SR
Semin Nephrol; 2023 Mar; 43(2):151409. PubMed ID: 37611335
[TBL] [Abstract][Full Text] [Related]
9. The Potential Modulatory Effects of Exercise on Skeletal Muscle Redox Status in Chronic Kidney Disease.
Mendes S; Leal DV; Baker LA; Ferreira A; Smith AC; Viana JL
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046990
[TBL] [Abstract][Full Text] [Related]
10. Review of muscle wasting associated with chronic kidney disease.
Workeneh BT; Mitch WE
Am J Clin Nutr; 2010 Apr; 91(4):1128S-1132S. PubMed ID: 20181807
[TBL] [Abstract][Full Text] [Related]
11. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486.
Xu J; Li R; Workeneh B; Dong Y; Wang X; Hu Z
Kidney Int; 2012 Aug; 82(4):401-11. PubMed ID: 22475820
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor NRF2 as potential therapeutic target for preventing muscle wasting in aging chronic kidney disease patients.
Gómez-García EF; Del Campo FM; Cortés-Sanabria L; Mendoza-Carrera F; Avesani CM; Stenvinkel P; Lindholm B; Cueto-Manzano AM
J Nephrol; 2022 Dec; 35(9):2215-2225. PubMed ID: 36322291
[TBL] [Abstract][Full Text] [Related]
13.
Wang B; Zhang A; Wang H; Klein JD; Tan L; Wang ZM; Du J; Naqvi N; Liu BC; Wang XH
Theranostics; 2019; 9(7):1864-1877. PubMed ID: 31037144
[TBL] [Abstract][Full Text] [Related]
14. Effect of endurance training and branched-chain amino acids on the signaling for muscle protein synthesis in CKD model rats fed a low-protein diet.
Yoshida T; Kakizawa S; Totsuka Y; Sugimoto M; Miura S; Kumagai H
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F805-F814. PubMed ID: 28701315
[TBL] [Abstract][Full Text] [Related]
15. Muscle wasting from kidney failure-a model for catabolic conditions.
Wang XH; Mitch WE
Int J Biochem Cell Biol; 2013 Oct; 45(10):2230-8. PubMed ID: 23872437
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA in myogenesis and muscle atrophy.
Wang XH
Curr Opin Clin Nutr Metab Care; 2013 May; 16(3):258-66. PubMed ID: 23449000
[TBL] [Abstract][Full Text] [Related]
17. Sarcopenia in Chronic Kidney Disease: Factors, Mechanisms, and Therapeutic Interventions.
Watanabe H; Enoki Y; Maruyama T
Biol Pharm Bull; 2019; 42(9):1437-1445. PubMed ID: 31474705
[TBL] [Abstract][Full Text] [Related]
18. Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact.
Rajan VR; Mitch WE
Pediatr Nephrol; 2008 Apr; 23(4):527-35. PubMed ID: 17987322
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of ER stress and unfolded protein response pathways in skeletal muscle health and disease.
Bohnert KR; McMillan JD; Kumar A
J Cell Physiol; 2018 Jan; 233(1):67-78. PubMed ID: 28177127
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin.
Thomas SS; Mitch WE
Clin Exp Nephrol; 2013 Apr; 17(2):174-82. PubMed ID: 23292175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
